Johnson & Johnson (JNJ) Cash from Operations Growth (5y) (2014 - 2026)

Johnson & Johnson (JNJ) Cash from Operations Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 -9.20%
Dec 28, 2025 -2.61%
Sep 28, 2025 1.81%
Jun 29, 2025 2.35%
Mar 30, 2025 4.45%
Dec 29, 2024 1.77%
Sep 29, 2024 1.21%
Jun 30, 2024 -1.08%
Mar 31, 2024 0.64%
Dec 31, 2023 4.72%
Oct 1, 2023 3.61%
Jul 2, 2023 -7.21%
Apr 2, 2023 -2.02%
Jan 1, 2023 -10.45%
Apr 3, 2022 6.44%
Apr 4, 2021 13.23%
Sep 27, 2020 6.43%
Jun 28, 2020 -8.80%
Mar 29, 2020 3.18%
Dec 29, 2019 6.80%